Aurora Cannabis Refutes Curaleaf's Latest Attempt To Distract Shareholders From The Facts
Aurora Cannabis publicly rebutted Curaleaf Holdings' application to halt Aurora's at-the-market equity program, calling the filing a distraction from a hostile bid that Aurora's board says significantly undervalues the company. Aurora counterpunched at Curaleaf's own balance sheet, citing more than $1 billion of debt including $500 million carrying an 11.5% interest rate, while emphasizing that Aurora itself is debt-free with a strong cash position. The board unanimously reiterated that shareholders should reject the hostile bid by taking no action and not tendering, and asked shareholders who already tendered to withdraw their shares.
Key figures
- Atm utilization
- inactive for several weeks; not utilized for three years prior to February 2026
- Asc complaint filed
- September 2, 2026
- Curaleaf total debt
- more than $1 billion
- Atm program announced
- February 2026
- Curaleaf high cost debt
- $500 million carrying an 11.5% interest rate
- Directors circular filed
- September 2, 2026
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.